• Latest Posts

What are the Best Countries to Recruit Biotech Talents in 2017?

The Patent Office has Spoken: What does it Mean for CRISPR in Europe?

The Largest Deals, Fundraising and Exits of 2016 in European Biotech

The 8 Biggest Biotech Medical Fails of 2016 in Europe

UPDATE: No Clear Winner in the CRISPR Patent Battle


CRISPR Thx’ surprisingly low IPO… why are Investors Discouraged?

€350M CRISPR Joint Venture now has a Name and an Office

CRISPR Therapeutics increases its Series B to a Massive €125M

CRISPR Thx in yet another Collaboration, this time for Muscle Dystrophy

Wow, Europe’s leading CRISPR Biotech signs monster €2.29 Billion Deal